Department of Orthopaedics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Spine J. 2011 Jul;11(7):641-6. doi: 10.1016/j.spinee.2011.04.025. Epub 2011 May 19.
Despite improvements through the use of prophylactic systemic antibiotics, surgical site infections remain a significant problem in the treatment of traumatic spine injuries. Infection rates as high as 10% have been reported in this population. The impact on patients and cost of treating such infections is profound. Local delivery of antibiotics has been found to be efficacious in animal and human studies as an adjunct to systemic antibiotics in surgical site infection prophylaxis.
To evaluate the efficacy of using vancomycin powder in surgical sites to prevent infections.
Retrospective case review.
Patients who underwent posterior spine fusions for traumatic injuries over a 2-year period at a single academic center.
Clinical outcome determined was the incidence of either superficial or deep postoperative wound infections.
A retrospective review of 110 patients with traumatic spine injuries treated with instrumented posterior spine fusions over a 2-year period at a single academic center was performed. One group (control group) received standard systemic prophylaxis only, whereas another (treatment group) received vancomycin powder in the surgical wound in addition to systemic prophylaxis. Patient demographics and perioperative information obtained included history of previous spine surgeries, substance use, diabetes, body mass index, level of injury, presence of neurologic deficit, operative time, and estimated blood loss. Incidence of infection was the primary outcome evaluated.
The control (N=54) and treatment groups (N=56) were statistically similar. A statistically significant difference in infection rate was found between the treatment group (0%) and control group (13%, p=.02) without any adverse events. No adverse effects were noted from use of the vancomycin powder.
The use of vancomycin powder in surgical wounds may significantly reduce the incidence of infection in patients with traumatic spine injuries treated with instrumented posterior spine fusion. Applying vancomycin powder to surgical wounds is a promising means of preventing costly and harmful postoperative wound infections in high-risk populations.
尽管预防性全身使用抗生素有所改善,但创伤性脊柱损伤的治疗中仍存在严重的手术部位感染问题。在该人群中,感染率高达 10%。治疗此类感染对患者和成本的影响是深远的。动物和人体研究发现,局部给予抗生素作为全身抗生素在预防手术部位感染中的辅助手段是有效的。
评估在手术部位使用万古霉素粉末预防感染的效果。
回顾性病例分析。
在一家学术中心接受后路脊柱融合术治疗创伤性损伤的患者,时间为 2 年。
确定的临床结果是术后浅表或深部伤口感染的发生率。
对一家学术中心在 2 年内接受后路脊柱融合术治疗创伤性脊柱损伤的 110 例患者进行回顾性回顾。一组(对照组)仅接受标准全身预防治疗,另一组(治疗组)除全身预防外,还在手术伤口中使用万古霉素粉末。获得的患者人口统计学和围手术期信息包括先前脊柱手术史、药物使用史、糖尿病、体重指数、损伤程度、神经功能缺损、手术时间和估计失血量。感染的发生率是评估的主要结果。
对照组(n=54)和治疗组(n=56)在统计学上相似。治疗组(0%)和对照组(13%)的感染率存在统计学显著差异(p=.02),且无任何不良事件。万古霉素粉末的使用未观察到任何不良反应。
在接受后路脊柱融合术治疗的创伤性脊柱损伤患者中,手术伤口中使用万古霉素粉末可能显著降低感染率。将万古霉素粉末应用于手术伤口是预防高危人群术后伤口感染的一种很有前途的方法。